Lantheus Holdings Культура компании

Mr. Michael P. Duffy has been Senior Vice President of Strategy & Business Development at Lantheus Holdings, Inc. since October 2015 and has been its Secretary and General Counsel since January 2008. Mr. Duffy has been a Vice President, Secretary and General Counsel at Lantheus Medical Imaging, Inc. since January 2008. He served as Vice President of Lantheus Holdings, Inc. since January 2008 until October 2015. Mr. Duffy served as a Senior Vice President, General Counsel and Secretary of Point Therapeutics Inc. from May 2002 to July 25, 2007. He is also Founder and Principal of a private business advisory firm. Prior to that, Mr. Duffy served as Senior Vice President, General Counsel and Secretary of Digital Broadband Communications, Inc. from 1999 to 2002. He served as Senior Vice President, General Counsel and Secretary of ETC w/tci, a sub-portfolio of TCI Ventures, Inc. / Liberty Media Corporation from 1996 to 1999. Mr. Duffy practiced law at Ropes & Gray in Boston, Massachusetts. Mr. Duffy began his legal career with Ropes & Gray in Boston. Mr. Duffy serves as Chairman of the Board of Directors of CORAR, the Council on Radionuclides and Radiopharmaceuticals, an international trade association for the radiopharmaceutical industry. He holds law degrees from the University of Pennsylvania and Oxford University and a Bachelor's degree in History of Science from Harvard College.

Dr. Cesare Orlandi, M.D., F.A.C.C. F.E.S.C., has been the Chief Medical Officer at Lantheus Holdings, Inc. since joining in March 6, 2013. Dr. Orlandi has been the Chief Medical Officer at Lantheus Medical Imaging, Inc. since March 6, 2013. He is responsible for leading Clinical Development, Medical Affairs, Pharmacovigilence and Regulatory Affairs for Lantheus Medical, including its Phase 3 clinical trial program for flurpiridaz F 18. From January 2012 to February 2013, he served as Senior Vice President and Chief Medical Officer of TransTech Pharma, Inc., where he led drug development from Phase 1 through Phase 3 trials for the company's pipeline programs. Prior to joining TransTech in January 2012, he served as Senior Vice President of Clinical Development and Chief Medical Officer of Cardiokine, Inc. from 2007 to 2011. He was responsible for the development, submission and regulatory approval of several compounds in the cardiovascular area. Dr. Orlandi has more than 20 years of diverse pharmaceutical industry experience with a proven track record of directing successful drug development programs, providing leadership in product pipeline portfolio management and overseeing interactions with regulatory agencies. Prior to joining Cardiokine, Dr. Orlandi was Vice President, Global Clinical Development at Otsuka Pharmaceuticals from 1998 to 2007, where he was responsible for a variety of programs including tolvaptan, a vasopressin receptor antagonist. He has also held the Vice President, Research & Development position with Medco Research, Inc., in Research Triangle Park, NC; Medical Director and Principal Investigator, Nuclear Cardiology positions with The DuPont Merck Pharmaceutical Company in North Billerica, MA; and was a visiting scientist with the Upjohn Company in Kalamazoo, MI. He is licensed and board certified in cardiology in Italy, where he served as Staff Physician in the Department of Internal Medicine, Ospedale S. Matteo and University of Pavia Medical School, Pavia, Italy. Dr. Orlandi has also held academic and hospital appointments at Harvard Medical School and Brigham and Women's Hospital in Boston, MA. He worked with the Radiopharmaceutical Division of Du Pont Merck Pharmaceutical Company, which is now Lantheus Medical Imaging. He is an Adjunct Assistant Professor of Medicine at Tufts University School of Medicine, Boston. He is a founding member of the American Society of Nuclear Cardiology (ASNC), a Fellow of the American College of Cardiology (ACC), European Society of Cardiology (ESC) and American College of Angiology (ACA). He is also a member of the ESC Industry Panel. He has also published an extensive number of original articles, reviews, books and abstracts. Dr. Orlandi received his M.D. with honors from the University of Pavia Medical School, Pavia, Italy.

Mr. John W. Crowley, also known as Jack, has been the Chief Financial Officer and Treasurer of Lantheus Holdings, Inc. since March 25, 2016. Mr. Crowley served as Interim Chief Financial Officer and Interim Treasurer of Lantheus Holdings, Inc. from December 10, 2015 to March 25, 2016. He also served as Chief Accounting Officer and Vice President of Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc. from March 2015 to December 2015. Mr. Crowley served as Vice President of Finance at Lantheus Holdings, Inc. from April 2013 to March 2015 and Director of Accounting from September 2010 to April 2013. Mr. Crowley served as Vice President of Finance at Lantheus Medical Imaging, Inc. until March 2015. Prior to joining Lantheus, Mr. Crowley served as an Assistant Corporate Controller of Biogen Idec. He served as Director of Accounting at Thermo Fischer Scientific and a Senior Manager in the Audit practice of PricewaterhouseCoopers LLP. Mr. Crowley holds a Master of Business Administration degree from the University of Massachusetts and a Bachelor of Science in Business Administration from Westfield State University and is a Certified Public Accountant (Massachusetts licensure, current status inactive).

Mr. William C. Dawes Jr. has been Vice President of Manufacturing and Operations at Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc. since November 2010. Mr. Dawes has nearly 15 years of manufacturing expertise. He served as Vice President of Manufacturing and Supply Chain at Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc. from January 2008 to November 2010. He served as Interim General Manager, Medical Imaging Technical Operations and Director, Engineering and Maintenance for BMSMI. He served as General Manager of Medical Imaging Technical Operations for Bristol-Myers Squibb Medical Imaging. Mr. Dawes began his career with DuPont Merck Pharmaceuticals where he built a strong operations background through positions of increasing responsibility in the areas of packaging, manufacturing and project engineering. Mr. Dawes received a Bachelors degree in Engineering from Hofstra University.

Robert Marshall serves as the Chief Financial Officer and Treasurer for Lantheus Medical Imaging. Robert started at Lantheus Medical Imaging in September of 2018. Robert is based in the Fort Wayne, Indiana Area.

Tim Healey serves as the Senior Vice President, Commercial of Lantheus Medical Imaging. Tim started at Lantheus Medical Imaging in Nov of 2015. Tim currently resides in the Greater Chicago Area.